7MAX 7-Hydroxy Meta Tabs
The 7MAX 7-Hydroxy Meta Tabs 25pk 2ct is a high-potency tablet product designed for adult retail environments such as smoke shops, specialty wellness stores, and extract-focused merchandising. Each display includes 25 individual packs, with 2 tablets per pack, formulated with 7-hydroxymitragynine (7-OH)—a concentrated alkaloid derived from Mitragyna speciosa known for its strength and fast-acting profile within the botanical extract category. Similar tablet-based 7-OH products are positioned for precision dosing and consistent potency, making them ideal for wholesale distribution and structured retail display systems.
This product is packaged in a multi-pack display format optimized for high-visibility merchandising, inventory control, and efficient shelf stocking. The 2-count pouch format supports convenient, grab-and-go retail sales while maintaining clear unit segmentation for pricing flexibility. Positioned within the premium 7-hydroxy extract segment, it appeals to experienced consumers seeking stronger alternatives to traditional kratom powders or capsules, while offering retailers a compact and scalable SKU for high-traffic environments.
As demand continues to grow for 7-hydroxy extract products and advanced alkaloid formulations, this SKU provides a high-turnover, high-margin option within the evolving extract category. The combination of 25-pack display configuration and dual-tablet units supports repeat purchases, streamlined merchandising, and effective integration into wholesale product assortments focused on high-potency botanical extracts.
WARNING
• 21+ only – adults of legal age only
• Concentrated extract product—7-hydroxymitragynine content
• Keep away from children & pets
• For retail resale only
• Follow local regulatory compliance
NOTE: Products containing concentrated 7-hydroxymitragynine carry significant health risks and lack FDA approval; they may pose serious opioid-like effects, and regulatory/legal status can vary by jurisdiction. Always follow applicable laws and health guidance.